Parametric Portfolio Associates’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $2.28M | Buy |
245,582
+49,289
| +25% | +$457K | ﹤0.01% | 2353 |
|
|
2021
Q4 | $1.92M | Buy |
196,293
+117,807
| +150% | +$1.15M | ﹤0.01% | 2460 |
|
|
2021
Q3 | $2.67M | Buy |
78,486
+29,427
| +60% | +$1,000K | ﹤0.01% | 2257 |
|
|
2021
Q2 | $1.8M | Buy |
49,059
+8,625
| +21% | +$316K | ﹤0.01% | 2494 |
|
|
2021
Q1 | $1.81M | Buy |
40,434
+3,444
| +9% | +$154K | ﹤0.01% | 2847 |
|
|
2020
Q4 | $2.11M | Buy |
36,990
+13,097
| +55% | +$747K | ﹤0.01% | 2619 |
|
|
2020
Q3 | $1.23M | Sell |
23,893
-5,136
| -18% | -$264K | ﹤0.01% | 2791 |
|
|
2020
Q2 | $1.73M | Sell |
29,029
-2,308
| -7% | -$138K | ﹤0.01% | 2588 |
|
|
2020
Q1 | $1.29M | Sell |
31,337
-7,064
| -18% | -$291K | ﹤0.01% | 2647 |
|
|
2019
Q4 | $2.39M | Buy |
38,401
+11,928
| +45% | +$742K | ﹤0.01% | 2582 |
|
|
2019
Q3 | $898K | Buy |
26,473
+237
| +0.9% | +$8.04K | ﹤0.01% | 3082 |
|
|
2019
Q2 | $592K | Buy |
26,236
+2,922
| +13% | +$65.9K | ﹤0.01% | 3293 |
|
|
2019
Q1 | $541K | Buy |
23,314
+1,995
| +9% | +$46.3K | ﹤0.01% | 3297 |
|
|
2018
Q4 | $447K | Sell |
21,319
-22,060
| -51% | -$463K | ﹤0.01% | 3363 |
|
|
2018
Q3 | $1.68M | Buy |
43,379
+9,209
| +27% | +$357K | ﹤0.01% | 2827 |
|
|
2018
Q2 | $1.35M | Buy |
+34,170
| New | +$1.35M | ﹤0.01% | 2901 |
|
|
2018
Q1 | – | Sell |
-17,894
| Closed | -$406K | – | 3970 |
|
|
2017
Q4 | $406K | Buy |
+17,894
| New | +$406K | ﹤0.01% | 3436 |
|